As it celebrates its 10th year, the ESMO International Symposium: 10th World Congress on Gastrointestinal Cancer has received endorsements from 6 leading professional societies and organizations, solidifying the reputation of the Congress as the premier platform for specialists in cancer research, leading oncologists and practicing clinicians to review the state-of-the-art in gastrointestinal cancer and share the latest information on its multidisciplinary management. The European Neuroendocrine Tumor Society (ENETS), European Oncology Nursing Society (EONS), European Organisation for Research and Treatment of Cancer (EORTC): Gastrointestinal Tumor Group, European School of Oncology (ESO), European Society of Surgical Oncology (ESSO), and Europacolon have indicated their support for the high quality of the scientific agenda and its educational value to oncology professionals. The European Society for Medical Oncology (ESMO) began its association with the Congress in 2005, and in 2008 brought the Congress under its educational wing as a partnership meeting.
In recognition of its 10 year history, Congress co-chair Eric Van Cutsem observed "We have much to celebrate from the past years. The number of deaths from colorectal cancer has been dropping as treatment has improved, allowing for more effective options for people with this diagnosis. However, there is still much work to be done. We are proud of our tradition of excellence in educating the medical community and look forward to continuing the journey."
The ESMO International Symposium: 10th World Congress on Gastrointestinal Cancer, developed and managed by Imedex, begins next week in Barcelona, Spain, running from 25-28 June 2008. More than 3,300 healthcare providers from nearly 100 countries are expected to attend. The internationally recognized faculty will include 68 experts, chaired by Mario Dicato, MD of the Luxembourg Medical Center in Luxembourg and Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium.
Designed to promote a multidisciplinary approach to treatment, the scientific agenda offers targeted sessions for oncology surgeons and nurses as well as a comprehensive range of topics for researchers, gastroenterologists, and medical and radiation oncologists. Presentation of cutting edge research has become one of the highlights of the Congress, as more than 400 abstracts have been accepted for publication in a special supplement of Annals of Oncology.
|Contact: Vanessa Pavinato|
European Society for Medical Oncology